FEBUXOSTAT- febuxostat tablet 
AbbVie Inc.

----------

febuxostat

PRINCIPAL DISPLAY PANEL - 40 mg 30 count Bottle Label

NDC 64764-918-30 Rx only
30 Tablets

Uloric
(febuxostat)
tablets

40 mg

Takeda logo

Do not accept if seal over
bottle opening is broken or
missing.

Usual Dosage: See package
insert.

Protect from light. Store at
25°C (77°F); excursions
permitted to 15-30°C
(59-86°F). (See USP
Controlled Room Temperature)

40 mg febuxostat per tablet.

Distributed by
Takeda Pharmaceuticals
America, Inc.
Deerfield, IL 60015

ULORIC is a registered trademark
of Teijin Limited and used
under license by Takeda
Pharmaceuticals America, Inc.



40mg30ctbottlelabel

PRINCIPAL DISPLAY PANEL - 80 mg 30 count Bottle Label

NDC 64764-677-30 Rx only
30 Tablets

Uloric
(febuxostat)
tablets

80 mg

Takeda logo

Do not accept if seal over
bottle opening is broken or
missing.

Usual Dosage: See package
insert.

Protect from light. Store at
25°C (77°F); excursions
permitted to 15-30°C
(59-86°F). (See USP
Controlled Room Temperature)

80 mg febuxostat per tablet.

Distributed by
Takeda Pharmaceuticals
America, Inc.
Deerfield, IL 60015

ULORIC is a registered trademark
of Teijin Limited and used
under license by Takeda
Pharmaceuticals America, Inc.



80mg30ctbottlelabel.jpg
FEBUXOSTAT 
febuxostat tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-9018
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
febuxostat (UNII: 101V0R1N2E) (febuxostat - UNII:101V0R1N2E) febuxostat40 mg
Inactive Ingredients
Ingredient NameStrength
lactose monohydrate (UNII: EWQ57Q8I5X)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
HYDROXYPROPYL CELLULOSE (1200000 MW) (UNII: RFW2ET671P)  
croscarmellose sodium (UNII: M28OL1HH48)  
silicon dioxide (UNII: ETJ7Z6XBU4)  
magnesium stearate (UNII: 70097M6I30)  
Product Characteristics
ColorGREEN (light green to green) Scoreno score
ShapeROUND (round shaped) Size9mm
FlavorImprint Code TAP;40
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-9018-3030 in 1 BOTTLE; Type 0: Not a Combination Product02/13/200905/31/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02185602/13/200905/31/2021
FEBUXOSTAT 
febuxostat tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-2677
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
febuxostat (UNII: 101V0R1N2E) (febuxostat - UNII:101V0R1N2E) febuxostat80 mg
Inactive Ingredients
Ingredient NameStrength
lactose monohydrate (UNII: EWQ57Q8I5X)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
HYDROXYPROPYL CELLULOSE (1200000 MW) (UNII: RFW2ET671P)  
croscarmellose sodium (UNII: M28OL1HH48)  
silicon dioxide (UNII: ETJ7Z6XBU4)  
magnesium stearate (UNII: 70097M6I30)  
Product Characteristics
ColorGREEN (light green to green) Scoreno score
ShapeTEAR (teardrop shaped) Size14mm
FlavorImprint Code TAP;80
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-2677-3030 in 1 BOTTLE; Type 0: Not a Combination Product02/13/200905/31/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02185602/13/200905/31/2021
Labeler - AbbVie Inc. (078458370)

Revised: 12/2017
Document Id: 7833294a-5f37-4cc7-817c-a855dc2ed880
Set id: e1e698fe-bb84-4277-abe3-4e24b2adf22f
Version: 13
Effective Time: 20171220
 
AbbVie Inc.